Invizyne Technologies, Inc. (IZTC)
NASDAQ: IZTC · Real-Time Price · USD
10.56
-0.29 (-2.67%)
Jan 17, 2025, 4:00 PM EST - Market closed
Company Description
Invizyne Technologies, Inc. operates as a synthetic biochemical company in the United States.
The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds.
Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion.
The company was founded in 2014 and is headquartered in Monrovia, California.
Invizyne Technologies, Inc.
| Country | United States |
| Founded | 2019 |
| IPO Date | Nov 13, 2024 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 29 |
| CEO | Michael Heltzen |
Contact Details
Address: 750 Royal Oaks Drive, Suite 106 Monrovia, California 91016 United States | |
| Phone | 626 415 1488 |
| Website | invizyne.com |
Stock Details
| Ticker Symbol | IZTC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $8.00 |
| CIK Code | 0002010788 |
| ISIN Number | US4618741098 |
| Employer ID | 83-4550057 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Michael Heltzen | Chief Executive Officer |
| Mohammad Hayat J.D. | Co-Founder, Chairman of the Board and President |
| Dr. Tyler Korman Ph.D. | Co-Founder and Vice President of Research |
| Dr. Paul Opgenorth Ph.D. | Co-Founder and Vice President of Development |
| James U. Bowie Ph.D. | Founder and Independent Director |
| Fouad Nawaz | Vice President of Finance |
| Lasse H. Gorlitz | Vice President of Communications |
| Michael Burns | Executive Vice President of Energy Transition |
| Dr. Zachary Karl Ph.D. | Vice President and Head of Business Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 19, 2024 | D | Notice of Exempt Offering of Securities |
| Nov 18, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Nov 18, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Nov 18, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Nov 18, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Nov 18, 2024 | 8-K | Current Report |
| Nov 12, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 424B4 | Prospectus |
| Nov 12, 2024 | 424B4 | Prospectus |
| Nov 12, 2024 | CERT | Certification by an exchange approving securities for listing |